Abstract-There are anecdotal reports of early cerebrovascular comphcatlons occurrmg m patients with glucocortlcoldremediable aldosteromsm (GRA) The issue has never been systematically evaluated In this study, we retrospectively reviewed the Internatlonal Repstry for GRA to see If there was an assoclatlon between cerebrovascular comphcatlons and GRA We searched the records of 376 patients from 27 genetically proven GRA pedigrees for premature death or cerebrovascular comphcatlons Each case was subsequently verified through the referring phynclan, or autopsy reports The number of comphcatlons occurrmg m patients with proven GRA were compared to GRA negative subjects from the same pedigrees There were 18 cerebrovascular events m 15 patients with proven GRA (n= 167) and none m the GRA negative group (n=194, P< 001) There were an additional 15 events m 15 subjects that were suspected of having GRA based on clmlcal history Seventy percent of events were hemorrhagic strokes, the overall case fatality rate was 61% The mean (2 SD) age at the time of the mltlal event was 31 72 11 3 years In total, 48% of all GRA pedigrees and 18% of all GRA patients had cerebrovascular comphcatlons, which 1s slmllar to the frequency of aneurysm m adult polycystlc kidney disease GRA 1s associated with high morbldlty and mortality from early onset of hemorrhage stroke and ruptured mtracramal aneurysms Screening for intracranial aneurysm with magnetic resonance anglography 1s advised for patients with genetically proven GRA (Hypertension. 1998;31[part 2]:445-450.)
G lucocortlcold-remediable aldosteromsm (GRA) 1s a rare form of pnmary aldosteromsm that results from a charactenstlc gene duphcatlon '** In this syndrome, which has an autosomal dominant mhentance pattern, aldosterone 1s produced and secreted under the sole control of adrenocortlcotropic hormone (ACTH) 3 Chmcally, GRA 1s characterized by moderate to severe hypertension with onset very early m life Plasma rerun actlvlty 1s generally suppressed Our evaluation of several GRA pedigrees diagnosed at our center, also revealed a prominent history of hemorrhagic stroke at an early age In order to investigate a possible relatlonshlp between GRA and cerebrovascular comphcatlons we evaluated 27 GRA pedigrees from the International Registry for GRA for a history of cerebrovascular disease or premature death
Methods

Subject Classification
The International Regstry for GKA was used to search for a hxtory of sudden or premature death and cerebrovascular death Because many of the events were documented m deceased mdlvlduals, not every patlent was avallable for testmg to confirm the dlagnosls of GRA Subjects were therefore classified as having proven GRA If they tested posmve for GRA through genetlc screenmg, ' had charactenstlc dexamethasone-suppression testing: or were known to be obligate carriers of the GRA gene Subjects were classified as sqxcted GRA If they had a clmlcal history consistent with GRA (such as early onset of hypertension) and were a member of a known GRA pedigree Results Sufflclent hlstoncal mformatlon was available m 376 members of 27 GFU pedigrees In total, 151 mdlvlduals were posmve for the gene duphcatlon that causes GRA on genetic testing In ad&tlon, 2 subjects had a positive dexamethasone suppression test,4 and 14 subJects were obligate carriers of the GRA gene Another 15 mdlvlduals, all of whom were at nsk of mhentmg the GRA gene, were suspected of being GFU posmve on the basis of their chmcal history These subJects were compared to 194 mdlvlduals from GRA pedigrees that underwent genetic screening and were negative for the GRA gene (Table 1) Patients were similar with respect to age, body mass index, gender, systolic blood pressure and plasma aldosterone There were more subjects with a history of hypertension m the GRA posmve group than the GFU negative group (72 7 versus , and age at which hypertension was documented (17 8tlO 4 versus 39 42 14 2 years, P< 00001) m GFU posltlve and negative subjects, respectively In total, vascular and cerebrovascular events were identified m 13 GRA pemgrees (48%) Proven Cases of GRA We found a total of 18 events m 15 proven GRA patients from 7 GRA pedigrees The diagnosis of GRA was confirmed through genetic testing m 9 mdlvlduals and through admmlstratlon of a dexamethasone suppression test m 2 mdlvlduals The remammg 4 patients were obligate carriers based on the genotype of other family members that underwent genetic testing Events (Table 2 ) consisted of early stroke (n=3), ruptured vascular aneurysm (n=6), mtracramal aneurysms that required surgcal clipping (n=2), cerebral hemorrhage without evldence of aneurysm (n=2), sudden death (n=l), vascular dlssectlon (n= I), and subarachnold hemorrhage without evldence of aneurysm (n=3) Three patients had two separate events conslstmg of recurrent early stroke, recurrent mtracrama1 aneurysm after prior aneurysmal rupture, and vascular dlssectlon of the carotid associated with an asymptomatlc intracranial aneurysm that required neurosurglcal clipping One additional patlent, who died of a ruptured middle cerebral artery aneurysm, was also found to have a second unruptured basilar artery aneurysm at autopsy The events were documented by autopsy (n=3), death certificates (n=2), radlographlc Imagmg (n=l I), and physician venficatlon (n=2) Gender dlstnbutlon was similar (9 male and 6 female), and the mean age of the patient at the time of their mmal event was 30 5 2 11 0 years The case fatality rate was 39% (7 fatalities m 18 events)
Proven GRA posluve patients with and without events were compared to GRA negative subjects (Table 3) AU patients wth proven GRA that had a cerebrovascular event had a history of hypertension Blood pressure measurements were available for 8115 of these patients The mean systohc and dlastohc blood pressures were, respectively, 147 8215 4 and 100 8?13 6 mm Hg This was higher than either systohc or dlastohc blood pressure m GRA negative (respectively, 133 3?16 0 and 80 31-10 5 mm Hg, P< 01) or GRA pontlve mthout events (respectively, 134 4+22 5 and 84 4217 2 mm Hg, P< 05) Hypertension was hagnosed at 12 3?6 4 years m GRA patients Mrlth events, which was slgmficantly younger than both GRA neganve patients (40 2Z 15 2 years, P<.OOOl) and GRA posltlve patients without events (18 4+10 3 years, P< 01) Smularly, GRA pauents mth events dffered from both GRA negative and GRA positive patients wthout events wth respect to plasma remn activity, and from GRA-negative patients with respect to plasma aldosterone and serum potassium (Table 3) A comparison of the number of vascular comphcatlons and sudden deaths that occurred m subjects proven to have GRA was compared to 136 members of the same pedigrees that tested negative for the GRA gene There were no events m the Abbreviations F, female, M, male, GS, genetic screening, DST, dexamethasone suppresslon test, obhgate, obligate carrier of GRA, SAH, subarachnoid hemorrhage, ES, early stroke, SD, sudden death, CH, cerebral hemorrhage, DC, death certificate, HTN, hypertension, BP, blood pressure levels on therapy prior to event, NA, not available, NAF, no aneurysm found GRA negative group which represents a highly significant difference (?=I3 6, P< 001)
Suspected Cases of GRA There were 15 events m 15 m&vlduals suspected to have GRA from a total of 9 GRA pedigrees None of the suspected GRA poslhve patients had genetically proven GRA, nor had they undergone dexamethasone suppression testmg However, all subjects were members of a genetically proven GRA pedigree The events observed m suspected GRA patients included early stroke (n=6), cerebral hemorrhage (n=6), ruptured vascular aneurysm (n=2), and sudden death (n=l) These events were documented by physician venficatlon (n=l), clmlcal history (n=9), death certificate (n=4), and autopsy (n=l) Suspected cases had a mean age of onset of 32 7t 11 6, and 12 of the 15 events occurred m males The case fatality rate was 87% Blood pressure measurements were not available m any of the suspected cases However, 10 mdlvlduals were reported to be hypertensive, and none of the remaining subjects were reported to have normal blood pressures.
When all of the events were considered together (proven plus suspected GRA patients), 70% of comphcahons involved hemorrhagc stroke, and 91% of cases were of the cerebrovasculature (Fig 1) With one exception, all aneurysms were cerebrovascular m nature The exception was the case of a 13-year-old boy with GRA proven through dexamethasone suppression testmg that died of a ruptured thoraclc aortlc aneurysm No cases of premature coronary artery &sease were defimtlvely documented An autopsy was performed on 1 of 2 cases of sudden death, a 39-year-old male with genetically proven GRA Evaluation of the coronary artenes m this subJect revealed nonngmficant coronary occlusion that was not felt to be the cause of death There was only one pahent with vascular dssecuon Data from the Framingham' study were used to compare the incidence rate of lschemlc and hemorrhagic stroke m GRA with normal mdlvlduals Incidence rates for lschemlc stroke were similar m the two groups, but the incidence of hemorrhagic stroke was dramatically higher m GRA patients compared to normals (Table 4) (7) Hemorrhagic stroke 0 020% 0 28% (13) 045% (23) Hemorrhagic stroke mcludes cerebral hemorrhage, subarachnoid hemorrhage and rupture or surgical repair of intracranial aneurysms Incidence rates are expressed as percent (number of events are shown in parentheses) ber of posslblhtles exist Toblan and colleagues have reported that correction of hypokalemla m the stroke prone hypertensive rat reduces their high rate of cerebral hemorrhage, even when blood pressure remains elevated I4 Hypokalemla-mduced cerebral hemorrhage 1s an unhkely explanation for our observations because, on average, GRA patients have been shown to have normal potassium levels and normal potassium homeostasls l5
A second posslblhty may relate to hyperaldosteromsm An assoclatlon between cerebrovascular disease and pnmary aldosteromsm has been described "-'* In GRA patients with events, aldosterone levels tended to be higher than those patients without events (Table 3 ) Like GRA, autosomal dominant polycystlc kidney disease 1s characterized both by aneurysm formation and aldosterone excess " Hyperaldosteromsm has also been shown to induce fibrosis of the rat heart20-22 and the systemic vasculature.23 It 1s possible that mmeralocortlcold-induced fibrosis of the cerebral vasculature could predispose these vessels to subsequent rupture Whether long-term hyperaldosteromsm 1s a causal lmk to intracranial aneurysm m both disorders 1s unknown.
Our findings could also relate to long-standmg hypertension since most of the comphcatlons occurred m hypertensive m&vlduals Many studies show an increased nsk of aneurysmal subarachnold hemorrhage m patients with hypertenslon,24-2" but other studies have found no such assoclatlon *'Pi') A final potential mechanism 1s that hypertension and/or mmeralocortlcold excess during the early stages of cerebrovascular development could predispose to aneurysm In support of this hypothesis are reports of increased cerebrovascular events (pnmanly cerebral hemorrhages) m a number of other congenital syndromes, including polycystlc kidney disease,'-" Llddle's syndrome,30 and congenital 1 l/3-hydroxylase deficiency 3' 32
The report of 4 cases of cerebral hemorrhage or premature death m a large Llddle's syndrome pedigree 1s particularly noteworthy 3o Like GRA subjects, Llddle's syndrome patients have suppressed plasma renm activity and generally have severe hypertension from childhood In contrast to GRA, Llddle's syndrome patients have suppressed aldosterone levels but are volume expanded due to mutations m the eplthehal sodium channel which constltutlvely activate sodium reabsorption 33-36 Although the number of events m this report30 are small, the sumlanty of findings suggests that the congenital nature of these hypertension syndromes may predispose to aneurysm formation Although not universally accepted, screening for asymptomatlc mtracramal aneurysm m polycystlc kidney disease 1s wldespread,7~37-40 and the frequency of comphcatlons m polycystic kidney disease (10 to 15%) 1s slmllar to that seen m GRA As a result, we recommend that all patients with genetically proven GRA should have MR angography to screen for intracranial aneurysm Since the vast maJonty of events occurred after puberty, it seems reasonable to begm screening at this time Based on the current practice m patients with autosomal dominant polycystlc kidney disease, screening should probably be repeated every 5 years '
In conclusion, our review of 27 pedigrees with genetically proven GRA has documented an increased prevalence of early cerebrovascular comphcatlons, prlmarlly cerebral hemorrhage, which 1s associated with high mortality (61%) The underlying mechanism of these intracranial hemorrhages relates to mtracranial aneurysm Since cerebrovascular comphcatlons were present m 18% of all patients shown to have GRA, we feel that screening of asymptomatic GRA patients with MR anglography should be performed, beginning at puberty and every five years thereafter (as m polycystlc kidney disease) 
